INTRODUCTION
Chronic mucocutaneous candidiasis (CMCC)1 is a rare disease often revealed in the first years of life, which Received for publication 2.9 Septemiiber 1977 and(c in revise(l formti 7Jtlil 1978. IAbbreviations uised1 int this paper: a-MM, alpham1etbyl-im1an1noside; AEF, absorbed an1d eluted fractioI; BSA, bovine serum albtumin; CA, Candida albicans; CMA, Candida metabolic antigen; CMCC, chronic mucocutanieous candidliasis; coin exhibits a high familial frequency (1) . Immunological disorders observed in CMCC are mainly represented by a defect of cell-mediated immunity, generally restricted to some antigens or exclusively to Catndida albicans (CA) itself. Negative-delayed hypersensitivity and sometimes abnormal in vitro proliferative response to Candida antigens were reported contrasting with normal or increased serum anti-Candida antibody (2) (3) (4) (5) . In some patients, the restoration of cellular responses to CA paralleled a clinical improvement with antifungal therapy, suggesting that cellular abnormalities were not a result of intrinsic lymphocytic defect (6, 7) . An inhibitory activity of normal lymphocyte proliferation was described in sera from 19 CMCC patients, all of them presenting an immune cellular defect (2, 6, (8) (9) (10) (11) (12) . In 13 cases the specificity of this inhibition seemed to be restricted to CA-induced proliferation (2, 9, 11) . Because the nature of the inhibitor present in the CMCC patients sera had not been studied, the purpose of this work was to characterize physicochemical properties of the inhibitory material and to establish whether there was any correlation between presence of a detectable serum inhibitor andl immunological disorders.
METHODS
Patienits. 23 patients (1-to 20-yr-old) with CMCC, were studied. Anti-Cantdidla antibodies were detected by electrosyneresis (13) . Delayed skin reactivity was tested with candidin (1:100,000 U in 0.1 ml saline) and tuberculin purified protein derivative (PPD) (Institut Pasteur, Paris) (10 U in 0.1 ml saline). Proliferative responses to Caudidan metabolic antigen (CMA), PPD, and mitogens were tested. Table I shows Louis, Mo.) were used at a concentration of 5-2,000 ,tg/ml.
Fractionation of patient's sera (Fig. 1 ). Sera were precipitated by adding a saturated (NH4) 2SO4 (pH 7.0) solution at a final concentration of 45%. Supernates and precipitates were separated.
Precipitates were washed three times in 45% (NH4) 2SO4, dissolved in distilled water, successively dialyzed against water and acetate buffer (pH. 5.0) then passed on a DEAESephadex A-50 (Pharmacia Fine Chemicals, Inc.) column equilibrated with an acetate-buffered saline (pH 5.0). Immunoglobulin (Ig)G-containing eluate was recuperated from the column by washing with the same buffer and passed on Sepharose 4B beads (Pharmacia Fine Chemicals, Inc.) covalently (BrCN) (15) bound to CMA antigens (8 mg protein/I ml Sepharose). Column was equilibrated successively with glycine (0.5 M), phosphate (0.1 M), pH 7.0, then Tris-HCl (0.1 M), NaCL (0.1 M) buffer, pH 7.3, then washed with glycine buffer (0.1 M, pH 2.5), and finally equilibrated in Tris-HCI (0.1 M), NaCL (0.1 M) buffer (pH 7.3). IgG-containing fractions were applied on the CMA column for 2 h at room temperature. Nonabsorbed fractions (NAF) were first recuperated by washing (20- Supernates, precipitate, and their fractions were extensively dialyzed against NaCl solutions (0.15 M) concentrated and dialyzed successively against polyethylene glycol, saline, and culture medium before assay in culture. Fractions were reconstituted to the initial volume of serum.
Fractionation of Candida antigens. The same procedures were followed for CMA and CSA which were passed on con A columns and fractionated into AEF and NAF. Estimation of proteins and carbohydrates contents was performed in serum fractions or dialyzed fluids with the Lowry et al. (16) and phenylsulphuric acid (17) methods.
Cell preparations. Normal mononuclear leukocytes from healthy volunteers with known prior sensitization to Candida were prepared with a Ficoll-Hypaque gradient (Pharmacia Fine Chemicals, Inc.) (18) washed three times in TC-199 medium (Gibco, Glasgow, Scotland) and cultured at a concentration of 1 x 10i cells/ml (0.5 ml/culture tube) in RPMI 1640 (Gibco) supplemented with antibiotics (penicillin G 50 U/ml, streptomycin 50 ,Ag/ml, gentamycin 50 /Ag/ml, amphotericin B 0.25 ,ug/ml, glutamine (1.5 mM/liter) (Institut Merieux, Lyon, France), and serum at various concentrations as indicated below.
Lymnphocyte proliferatiot studies. Cell cultures were incubated at 37°C in a 5% CO2 atmosphere. Cells stimulated with con A (Miles, Yeda, Israel) at a final concentration of 10 ,ug/ml were cultured for 4 days; cells stimulated with antigens for 6 days. 1 ,uCi of [3H]thymidine (3H-T) (Commissariat a l'Energie Atomique, Saclay, France) per milliliter of culture fluid was added to each culture 18 h before harvesting. Incorporation of 3H-T was measured with a paper disk technique (19) . Tubes were prepared in duplicate for experimental and, at least, in triplicate for control cultures, and two samples from each tube were tested. The range of normal response to CMA was 25,000-100,000 cpm/tube and spontaneous 3H-T incorporation ranged 700-1,500 cpm/tube. No attention was given to the presence of antibodies directed against blood group substances in serum samples. Indeed, preliminary experiments had established that proliferative responses in cultures performed in the presence of sera from various A, B, or 0 normal individuals were similar.
Assay for inhibition of Candida-induced proliferation and quantitation of the inhibitory effects. Inhibitory effect of patient's serum was studied on lymphocytes from normal Candida-sensitized individuals stimulated with CMA (0.25 mg/ml). Cultures were performed, with one exception, at a constant final concentration of AB' serum (10%) and variable concentration (0-10%) of patient's serum or their fractions. The amount of serum or serum fraction added to cultures was expressed as the percentage: volume of serum or serum fraction x 100/vol of serum or serum fraction plus volume of (AB+) serum.
Results were compared to those obtained in control cultures (10% AB+ serum alone). The inhibition of proliferative reSpecific Seric Inhibitor in Chronic Candidiasis sponses by the patient's serum or their fractions was expressed as the ratio: 3H-T incorporation (counts per minute per tube) in control culture minus 3H-T incorporation (counts per minute per tube) in experimental culture/3H-T incorporation incorporation (counts per minute per tube) in control culture x 100. Percentage of blasts among culture cells was determined on smears stained with May-Grunwald-Giemsa.
RESULTS
Inhibitory activity of unfractiontated patients' sera on CMA-induced lymphocyte proliferation. The detection of an inhibitory effect present in the serum of patients with CMCC was first assayed by culturing normal lymphocytes in the presence of an optimal concentration of CMA (0.25 mg/ml) with an equal volume of AB+ (10%) and patient (10%) serum. Results were compared with cultures in 10 and 20% AB+ serum. Among the 23 patients' sera tested, 6 showed a concomitant inhibitory activity on proliferation (>50% inhibition) and blastogenesis whereas 10 normal sera tested under the same conditions did not display any of these effects (Fig. 2) . For the purpose of this study, we investigated only the six sera showing an inhibitory activity of >50% inhibition.
We used suboptimal doses of antigen: CMA in stimulating normal lymphocytes in presence of suppressive material from one CMCC patient displaying an inhibitory activity (patient F.B.). We found no change in the intensity of inhibition:-50% from 0.025 mg to 0.50 mg of CMA. As shown in Fig. 3A Anttigent specificity of the inhibitory activity (Fig. 3 ).
To establish whether the inhibitory activity observed was specific for CMA-induced proliferation, the effect of patients' sera was simultaneously studied on PPDor con A-induced lymphocyte proliferative responses. Only one patient's serum (H.G.) (lisplayed a mild inhibitory activity on PPD-induced lymphocyte proliferation. This effect was signlificantly lower than that obtained with the same serum on CMA-indsoced proliferation (P < 0.01) (Student's t test).
Absetnce of cytotoxicity of patientts' sera o1 normal lymphocyte and reversibility of the inihibitory effect. The viability (trypan blue exclusion) of normal lymphocytes, 6 days after stimulation with CMA, was identi- cal whether cultures were performed in the presence of normal AB+ serum (10%) (viability: 77+5%) or in the presence of inhibitory sera (10%) added to 10% AB+ serum (viability: 74±10%). The spontaneous incorporation of 3H-T by normal, nonstimulated lymphocytes cultured for 6 days was the same whether normal serum (1,230±165 cpm) or inhibitory serum plus normal serum (vol/vol) (1,159±120 cpm) were added to the cultures. Normal leukocytes were incubated for 24 h in the presence of inhibitory or normal serum, then washed and stimulated by CMA in normal serum for the remaining 5 days, showed identical capacity ofproliferation.
Thermostability and dialysis studies. When frozen at -20°C for periods varying from 1 day to 2 yr, patients' sera maintained their inhibitory activity. The effect was not altered by dialysis or by heating at 56°C for 30 min. In other experiments, heating at 80°C for 30 min followed by a centrifugation (3,000 rpm for 10 min) to remove denatured proteins, did not lessen the inhibitory effect. Control sera did not exert any inhibitory activity after heating at 80°C for 30 min.
Inhibitory activity of serum fractions obtained by salt precipitation on CMA-induced lymphocyte proliferation. When sera were fractionated by precipitation in ammonium sulfate, the precipitable fraction did not retain the same inhibitory activity that was recovered in the supernates. The same fractions from either a pool of normal sera or one CMCC patient's serum without inhibitory activity, did not exhibit any inhibition (Table II) . No inhibitory activity, initially present in patients' sera was recovered in IgG-containing eluates obtained from a DEAE-Sephadex A-50 column, or in IgG eluated from a Sepharose CMA column.
Inthibitory activity of serum fractionts obtained by affinity chromatography on CMA-iniduced lymphocyte proliferation (Fig. 4) . Supernatant fractions obtained after ammonium sulfate precipitation from three inhibitory patients' sera were passed through anti- 
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Candida antiserum, con A-or BSA-Sepharose columns. The same fractions from normal AB+ and noninhibitory patients' sera were studied. The inhibitory activity present in supernatant fractions was not detected in NAF from anti-Candida antiserum column. In contrast the inhibitory activity was found in AEF of antiCandida column. When compared with supernatant fraction, AEF had a higher carbohydrate protein ratio. The inhibitory activity was also retained on con A-Sepharose columns and was eluted using a-MM. Again, AEF from con A column was enriched in carbohydrates when compared with the supernate. In contrast, BSA columns did not retain the inhibitory activity. When normal sera or noninhibitory patient's serum were passed through anti-Candida or con A columns, no inhibitory activity was retained. Effect of CMA, CSA, or their carbohydrate-rich components on CMA-induced lymphocyte proliferation (Fig. 5) . In these experiments, CMA and CSA were passed through a con A-Sepharose column. The inhibitory activity of NAF and AEF were studied at various concentrations of carbohydrate contents. AEF, that contained carbohydrate with affinity to con A appeared to exert, at the same carbohydrate concentration, a stronger inhibitory activity than NAF or crude (CMA or CSA) antigens.
Inhibitory activity of mannan from CA or CMAinduced lymphocyte proliferation (Fig. 6 ). An inhibitory activity was observed when mannan from CA (A or B) was added at a concentration of 50 ,ug/ml or more to the culture. This inhibitory effect appeared to be specific for CMA because concentrations ranging from 50 to 500 ug/ml did not modify PPD-or con A-induced proliferation. However, a mild inhibition (50%) was detectable on PPD-induced proliferative (pg/ml) FIGURE 6 Percentage of inhibition induced by mannan from CA (A), dextran (B), and a-MM (C) on proliferative responses of normal lymphocytes to CMA. Carbohydrate concentrations varied from 5 to 2,000 ,ug/ml of culture.
response when a much larger concentration (1,000 ,ug/ml) of mannan was used. Mannan added to nonstimulated lymphocyte cultures did not exert any mitogenic activity whatever the concentration used (5-2,000 ,ug/ml). Dextran and a-MM did not exhibit any inhibitory activity on CMA-induced lymphocyte proliferation.
Longitudinal studies of clinical and immunological data of patients with serum inhibitor (Table III) . In three patients under antifungal therapy, clinical improvement was observed together with the disappearance of the inhibitory activity when proliferative response and skin reactivity to CMA became present.
DISCUSSION
An inhibitory activity on Candida antigens-induced proliferative response ofnormal lymphocytes was detected in 6 out of 23 patients' sera, having chronic mucocutaneous candidiasis. This inhibitory activity appeared to be directly dependent on a patient's serum concentration, allowing for its quantization not achieved in previous studies (2, 6, 8, 10, 11) . These previous observations have shown that specific inhibition for Candida-induced proliferation was found in most (13 out of 19 ) CMCC patients' sera tested (2, 9, 11) . In six inhibitory patients' sera investigated in this study, only one was found to be slightly inhibitory on PPD-induced proliferative response. As already described in another series of CMCC patients (2), the six patients who had a serum inhibitory activity exhibited a selective unresponsiveness to Candida antigens, i.e., negative-delayed skin hypersensitivity and absence of in vitro proliferative response in homologous serum.
Our study was aimed at further characterizing the nature of the inhibitor present in the serum of the six patients. Because an inhibition was observed at a 2% final concentration of patient's sera, the effect (Table III) showed a correlation between clinical improvement under antifungal therapy, disappearance of the serum inhibitory activity, and appearance of in vivo and in vitro cell-mediated responses to Candida antigens. The reversible specific cellular deficiency observed in CMCC could thus be secondary to an overload of Candida polysaccharide antigens which may contribute to the chronicity of the disease by inducing the immune cellular unresponsiveness. Indeed, free Candida antigens mannan, were detected in the serum of patients with acute invasive candidiasis (26) . High antibody titers against Candida antigens (including antimannan antibodies) (21) are usually detected in CMCC patients (4) . This, however, does not exclude that poorly immunogenic Candida antigens, including glucan (27) , may escape the humoral response. In experiments with antiCandida antibody coupled columns, glucan could be absorbed as the peptido-gluco-mannan complex of the Candida cell wall (24) . A more attractice hypothesis, however, could be an impaired catabolism of polysaccharidic materials by macrophages of patients with CMCC. In that respect, the physiological resistance of glucan (which provokes granuloma when injected intravenously in mice) to enzymatic degradation by macrophages should be underlined (28) . We may speculate that an abnormality of the macrophages in patients with CMCC may underlie the disease. This situation is, somehow, reminiscent of high-responder mouse strain in which high production of antibodies contrasting with a low catabolism of antigens by macrophages has been demonstrated (29) .
The mechanism of the inhibition of free antigens of the T-cell proliferation remains a matter of speculation. One could envisage a competition for specific antigen receptors on the membrane of T cells, circulating antigen, and antigens handled by macrophages (30) . The antigenic excess may also induce a specific suppressive cell active on the cellular but not humoral immune response.
Some CMCC patients with a reversible specific cellular immune defect, that we have observed or who have been reported (31) , had no detectable serum inhibitor. It is possible that other mechanisms are involved in the acquired immunodeficiency of those patients (1, 5, 31) . In these patients, it cannot be ruled out that a local, nondiffusible, inhibitory activity of Candida-specific cellular response is mediated by high concentration of Candida polysaccharides in the skin and mucosal lesions. In all cases, clearing the overload of Candida antigens by potent and prolonged antifungal therapy might be the best way to restore the cellular immune response.
